Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Wigs significantly improve the well-being of people with severe hair loss.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

New therapies for alopecia areata show potential but need more research.

Yellow dots are common in severe alopecia areata.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

Horse alopecia areata is rare and mainly affects their appearance.